---
figid: PMC3884108__ijgm-6-877Fig2
figlink: /pmc/articles/PMC3884108/figure/f2-ijgm-6-877/
number: F2
caption: 'Cell mechanism linking impaired glucose utilization in type 2 diabetes and
  cardiovascular disease. Insulin signal transduction in individuals with normal glucose
  tolerance (A) and with type 2 diabetes (B). Insulin signaling through IRS-1 is impaired
  in type 2 diabetes, leading to decreased glucose transport/phosphorylation/metabolism
  and impaired NOS activation/endothelial function. Insulin resistance in the IRS-1/PI-3
  kinase pathway results in compensatory hyperinsulinemia, excessive stimulation of
  the MAP kinase pathway, and subsequent inflammation, cell proliferation, and atherogenesis.Abbreviations:
  IRS-1, insulin-receptor substrate 1; NOS, nitric oxide synthase; PI-3, phosphoinositide
  3; MAP, mitogen-activated protein; SHC, Src-homology collagen.'
pmcid: PMC3884108
papertitle: 'Pathogenesis and management of postprandial hyperglycemia: role of incretin-based
  therapies.'
reftext: John Gerich. Int J Gen Med. 2013;6:877-895.
pmc_ranked_result_index: '25600'
pathway_score: 0.9597009
filename: ijgm-6-877Fig2.jpg
figtitle: Cell mechanism linking impaired glucose utilization in type 2 diabetes and
  cardiovascular disease
year: '2013'
organisms:
- Homo sapiens
ndex: c7b2a8f6-deb6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3884108__ijgm-6-877Fig2.html
  '@type': Dataset
  description: 'Cell mechanism linking impaired glucose utilization in type 2 diabetes
    and cardiovascular disease. Insulin signal transduction in individuals with normal
    glucose tolerance (A) and with type 2 diabetes (B). Insulin signaling through
    IRS-1 is impaired in type 2 diabetes, leading to decreased glucose transport/phosphorylation/metabolism
    and impaired NOS activation/endothelial function. Insulin resistance in the IRS-1/PI-3
    kinase pathway results in compensatory hyperinsulinemia, excessive stimulation
    of the MAP kinase pathway, and subsequent inflammation, cell proliferation, and
    atherogenesis.Abbreviations: IRS-1, insulin-receptor substrate 1; NOS, nitric
    oxide synthase; PI-3, phosphoinositide 3; MAP, mitogen-activated protein; SHC,
    Src-homology collagen.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NOS3
  - AKT3
  - AKT1
  - AKT2
  - SLC2A4
  - NOS1
  - SHC2
  - SHC4
  - NOS2
  - IRS1
  - SHC3
  - SART3
  - SLC2A1
  - SHC1
  - Glucose
genes:
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS2
  entrez: '4843'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
diseases: []
figid_alias: PMC3884108__F2
redirect_from: /figures/PMC3884108__F2
figtype: Figure
---
